Stockscreener 앱 받기
57.33
3.58%
-2.13
시장 영업 전:
57.37
0.04
+0.07%
Biomarin Pharmaceutical Inc 주식(BMRN)의 최신 뉴스
The Top 12 Companies Hiring in Biopharma Now - BioSpace
Positive Earnings Growth Hasn't Been Enough to Get BioMarin Pharmaceutical (NASDAQ:BMRN) Shareholders a Favorable Return Over the Last Five Years - 富途牛牛
BioMarin Pharmaceutical Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Yahoo Finance
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q2 2025 Earnings Call Transcript - Insider Monkey
BioMarin Pharmaceutical (BMRN) Receives a Buy from Stifel Nicolaus - The Globe and Mail
BioMarin Pharmaceutical Inc. Reports Strong Q2 2025 Results - The Globe and Mail
BioMarin’s Earnings Call: Growth Amid Challenges - TipRanks
BioMarin: Acquisition Of Inozyme Brings Forth Late-Stage ERT BMN 401 (NASDAQ:BMRN) - Seeking Alpha
Research Alert: CFRA Keeps Buy View On Shares Of Biomarin Pharmaceutical Inc. - 富途牛牛
BIOMARIN PHARMACEUTICAL INC SEC 10-Q Report - TradingView
BioMarin Discontinues Preclinical Drug Candidate, Advances BMN 333 Toward 2030 - inkl
BioMarin stock rating reiterated at Buy by Stifel on strong Q2 results - Investing.com
BMRN Makes Bullish Cross Above Critical Moving Average - Nasdaq
BioMarin touts promising early result for potential Voxzogo successor - Fierce Pharma
UBS Adjusts Price Target on BioMarin Pharmaceutical to $114 From $113, Maintains Buy Rating - MarketScreener
BioMarin Axes Pre-Clinical PKU Drug, Citing Underwhelming Immunogenicity - BioSpace
BioMarin Beats on Q2 Earnings & Sales, Stock Gains on Raised '25 View - Yahoo Finance
BioMarin raises 2025 full-year guidance with $3.125B revenue target and advances BMN 333 - MSN
BioMarin: Q2 Earnings Snapshot - New Haven Register
BioMarin Pharmaceutical Inc (BMRN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
BioMarin’s Earnings Beat Forecasts And Hike Guidance For 2025 - Finimize
BioMarin Pharmaceutical Q2 2025 Earnings Call Transcript - MarketBeat
BioMarin (BMRN) Q2 Revenue Jumps 16% - The Motley Fool
BioMarin (BMRN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Earnings call transcript: Biomarin beats Q2 2025 estimates, stock rises By Investing.com - Investing.com Canada
Earnings call transcript: Biomarin beats Q2 2025 estimates, stock rises - Investing.com
BioMarin Pharmaceutical (BMRN) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance
BioMarin Pharmaceutical Reports Strong Q2 EarningsNews and Statistics - IndexBox
Biomarin Pharmaceutical Inc. Bottom Line Rises In Q2 - Nasdaq
BioMarin Pharmaceutical (NASDAQ:BMRN) Delivers Strong Q2 Numbers, Stock Soars - TradingView
BioMarin Pharma Q2 revenue beats estimates - MarketScreener
Earnings Flash (BMRN) BioMarin Pharmaceutical Inc. Reports Q2 Revenue $825.0M, vs. FactSet Est of $761.7M - MarketScreener
BioMarin Reports Strong Second Quarter 2025 Results and Raises Full-year Guidance¹ for Total Revenues, Non-GAAP Operating Margin, and Non-GAAP Diluted EPS - PR Newswire
What makes BioMarin Pharmaceutical Inc. stock price move sharplyGet real-time alerts on top-performing stocks - Jammu Links News
How does BioMarin Pharmaceutical Inc. compare to its industry peersBuild a portfolio that grows with the market - Jammu Links News
Is BioMarin Pharmaceutical Inc. a good long term investmentCapitalize on emerging industry trends - Jammu Links News
How volatile is BioMarin Pharmaceutical Inc. stock compared to the marketHigh-octane gains - Jammu Links News
What is the dividend policy of BioMarin Pharmaceutical Inc. stockSuperior trading gains - Jammu Links News
BioMarin Pharmaceuticals Appoints Ian T. Clark to Board of Directors - AInvest
When is BioMarin Pharmaceutical Inc. stock expected to show significant growthBuild capital through low-risk investments - Jammu Links News
What is BioMarin Pharmaceutical Inc. company’s growth strategySky-high profits - Jammu Links News
Is it the right time to buy BioMarin Pharmaceutical Inc. stockAchieve consistent profits with proven methods - Jammu Links News
What are analysts’ price targets for BioMarin Pharmaceutical Inc. in the next 12 monthsSuperior investment outcomes - Jammu Links News
Published on: 2025-08-03 23:11:15 - Jammu Links News
What catalysts could drive BioMarin Pharmaceutical Inc. stock higher in 2025Unlock powerful stock screening for profits - Jammu Links News
What are the technical indicators suggesting about BioMarin Pharmaceutical Inc.Free Bull & Bear Market Updates - Jammu Links News
How strong is BioMarin Pharmaceutical Inc. company’s balance sheetTremendous wealth creation - Jammu Links News
Is BioMarin Pharmaceutical Inc. a growth stock or a value stockMaximize returns with smart investment plans - Jammu Links News
What are BioMarin Pharmaceutical Inc. company’s key revenue driversConsistent high-yield stocks - Jammu Links News
BioMarin Pharmaceutical (BMRN) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
BioMarin Expands Board with New Director Appointment - MSN
0.24%
3.39%
자본화:
|
볼륨(24시간):